Possible involvement of TLRs and hemichannels in stress-induced CNS dysfunction via mastocytes, and glia activation

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Aguirre, Adam ^a,b   Maturana, Carola J ^a,b   Harcha, Paloma A ^a,b   Sáez, Juan C ^a,b  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b Centro Interdisciplinario de Neurociencias de Valparaíso   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; GLUTAMIC ACID; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR; CALCIUM; GAP JUNCTION PROTEIN; GLUCOCORTICOID; LIGAND;

ASTROCYTE; BRAIN CELL; CELL SURFACE; CENTRAL NERVOUS SYSTEM DISEASE; GLIA CELL; HUMAN; INFLAMMATION; MAST CELL; MEMBRANE; MYELINATION; PREGNANCY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SUBUNIT; REVIEW; STRESS; VIRUS INFECTION; BRAIN; CELL MEMBRANE; CENTRAL NERVOUS SYSTEM; CYTOLOGY; FEMALE; GLIA; METABOLISM; MICROGLIA; PREGNANCY COMPLICATION; SIGNAL TRANSDUCTION;

ADENOSINE TRIPHOSPHATE; ASTROCYTES; BRAIN; CALCIUM; CELL MEMBRANE; CENTRAL NERVOUS SYSTEM; CONNEXINS; FEMALE; GLUCOCORTICOIDS; GLUTAMIC ACID; HUMANS; INFLAMMATION; LIGANDS; MAST CELLS; MICROGLIA; NEUROGLIA; PREGNANCY; PREGNANCY COMPLICATIONS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84880851211     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/893521     Document Type: Review

References (253)

1. Carson M. J., Doose J. M., Melchior B., Schmid C. D., Ploix C. C., CNS immune privilege: hiding in plain sight. Immunological Reviews 2006 213 1 48 65 2-s2.0-33748743268 10.1111/j.1600-065X.2006.00441.x (Pubitemid 44401493)
2. Theoharides T. C., Mast cells: The immune gate to the brain. Life Sciences 1990 46 9 607 617 2-s2.0-0025055444 10.1016/0024-3205(90)90129-F (Pubitemid 20056884)
3. Turrin N. P., Rivest S., Molecular and cellular immune mediators of neuroprotection. Molecular Neurobiology 2006 34 3 221 242 2-s2.0-33847043183 10.1385/MN:34:3:221
4. Frank-Cannon T. C., Alto L. T., McAlpine F. E., Tansey M. G., Does neuroinflammation fan the flame in neurodegenerative diseases? Molecular Neurodegeneration 2009 4 1, article 47 2-s2.0-72449204160 10.1186/1750-1326-4-47
5. Rivest S., Regulation of innate immune responses in the brain. Nature Reviews Immunology 2009 9 6 429 439 2-s2.0-66449130960 10.1038/nri2565
6. Block M. L., Zecca L., Hong J.-S., Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nature Reviews Neuroscience 2007 8 1 57 69 2-s2.0-33845768784 10.1038/nrn2038 (Pubitemid 46011999)
7. Theoharides T. C., Donelan J., Kandere-Grzybowska K., Konstantinidou A., The role of mast cells in migraine pathophysiology. Brain Research Reviews 2005 49 1 65 76 2-s2.0-20444391699 10.1016/j.brainresrev.2004.11.006 (Pubitemid 40800163)
8. Mallard C., Wang X., Hagberg H., The role of Toll-like receptors in perinatal brain injury. Clinics in Perinatology 2009 36 4 763 772 2-s2.0-70450201440 10.1016/j.clp.2009.07.009
9. McCurdy J. D., Olynych T. J., Maher L. H., Marshall J. S., Cutting edge: Distinct toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells. Journal of Immunology 2003 170 4 1625 1629 2-s2.0-0037442003 (Pubitemid 36197374)
10. Frank M. G., Thompson B. M., Watkins L. R., Maier S. F., Glucocorticoids mediate stress-induced priming of microglial pro-inflammatory responses. Brain, Behavior, and Immunity 2012 26 2 337 345 2-s2.0-84855985525 10.1016/j.bbi.2011. 10.005
11. Okun E., Griffioen K. J., Lathia J. D., Tang S.-C., Mattson M. P., Arumugam T. V., Toll-like receptors in neurodegeneration. Brain Research Reviews 2009 59 2 278 292 2-s2.0-60449109146 10.1016/j.brainresrev.2008.09.001
12. Iribarren P., Zhou Y., Hu J., Le Y., Wang J. M., Role of formyl peptide receptor-like 1 (FPRL1/FPR2) in mononuclear phagocyte responses in Alzheimer disease. Immunologic Research 2005 31 3 165 176 2-s2.0-18244407519 10.1385/IR:31:3:165 (Pubitemid 40628955)
13. Arroyo D. S., Soria J. A., Gaviglio E. A., Rodriguez-Galan M. C., Iribarren P., Toll-like receptors are key players in neurodegeneration. International Immunopharmacology 2011 11 10 1415 1421 2-s2.0-80053289163 10.1016/j.intimp.2011.05.006
14. Brown A. S., Begg M. D., Gravenstein S., Schaefer C. A., Wyatt R. J., Bresnahan M., Babulas V. P., Susser E. S., Serologic evidence of prenatal influenza in the etiology of schizophrenia. Archives of General Psychiatry 2004 61 8 774 780 2-s2.0-3543093977 10.1001/archpsyc.61.8.774 (Pubitemid 39031117)
15. Brown A. S., Prenatal infection as a risk factor for schizophrenia. Schizophrenia Bulletin 2006 32 2 200 202 2-s2.0-33645217100 10.1093/schbul/ sbj052
16. Meyer U., Nyffeler M., Engler A., Urwyler A., Schedlowski M., Knuesel I., Yee B. K., Feldon J., The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. Journal of Neuroscience 2006 26 18 4752 4762 2-s2.0-33646926705 10.1523/JNEUROSCI.0099-06. 2006 (Pubitemid 44315314)
17. Meyer U., Feldon J., To poly(I:C) or not to poly(I:C): Advancing preclinical schizophrenia research through the use of prenatal immune activation models. Neuropharmacology 2012 62 3 1308 1321 2-s2.0-84856095635 10.1016/j.neuropharm.2011.01.009
18. Arrode-Brusés G., Brusés J. L., Maternal immune activation by poly I:C induces expression of cytokines IL-1 β and IL-13, chemokine MCP-1 and colony stimulating factor VEGF in fetal mouse brain. Journal of Neuroinflammation 2012 9 83 10.1186/1742-2094-9-83
19. Brown A. S., Exposure to prenatal infection and risk of schizophrenia. Frontiers in Psychiatry 2011 2 63 10.3389/fpsyt.2011.00063
20. Asadi S., Theoharides T. C., Corticotropin-releasing hormone and extracellular mitochondria augment IgE-stimulated human mast-cell vascular endothelial growth factor release, which is inhibited by luteolin. Journal of Neuroinflammation 2012 85 2-s2.0-84860517661 10.1186/1742-2094-9-85
21. Akira S., Uematsu S., Takeuchi O., Pathogen recognition and innate immunity. Cell 2006 124 4 783 801 2-s2.0-32944464648 10.1016/j.cell.2006.02.015 (Pubitemid 43261452)
22. Liu T., Gao Y.-J., Ji R.-R., Emerging role of Toll-like receptors in the control of pain and itch. Neuroscience Bulletin 2012 1 14 2-s2.0-84857461539 10.1007/s12264-012-1219-5
23. Heil F., Hemmi H., Hochrein H., Ampenberger F., Kirschning C., Akira S., Lipford G., Wagner H., Bauer S., Species-specific recognition of single-stranded RNA via till-like receptor 7 and 8. Science 2004 303 5663 1526 1529 2-s2.0-1542317578 10.1126/science.1093620 (Pubitemid 38314424)
24. Yarovinsky F., Zhang D., Andersen J. F., Bannenberg G. L., Serhan C. N., Hayden M. S., Hieny S., Sutterwala F. S., Flavell R. A., Ghosh S., Sher A., Immunology: TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 2005 308 5728 1626 1629 2-s2.0-20644433342 10.1126/science. 1109893 (Pubitemid 40807512)
25. Town T., Jeng D., Alexopoulou L., Tan J., Flavell R. A., Microglia recognize double-stranded RNA via TLR3. Journal of Immunology 2006 176 6 3804 3812 2-s2.0-33644833702 (Pubitemid 43364029)
26. Dimitriadou V., Lambracht-Hall M., Reichler J., Theoharides T. C., Histochemical and ultrastructural characteristics of rat brain perivascular mast cells stimulated with compound 48/80 and carbachol. Neuroscience 1990 39 1 209 224 2-s2.0-0025248392 10.1016/0306-4522(90)90234-U
27. Manning K. A., Pienkowski T. P., Uhlrich D. J., Histaminergic and non-histamine-immunoreactive mast cells within the cat lateral geniculate complex examined with light and electron microscopy. Neuroscience 1994 63 1 191 206 2-s2.0-0028149577 10.1016/0306-4522(94)90016-7 (Pubitemid 24333961)
28. Michaloudi H., Batzios C., Chiotelli M., Papadopoulos G. C., Developmental changes of mast cell populations in the cerebral meninges of the rat. Journal of Anatomy 2007 211 4 556 566 2-s2.0-34648823387 10.1111/j.1469-7580.2007.00795.x (Pubitemid 47456841)
29. Khalil M., Ronda J., Weintraub M., Jain K., Silver R., Silverman A.-J., Brain mast cell relationship to neurovasculature during development. Brain Research 2007 1171 1 18 29 2-s2.0-34548640694 10.1016/j.brainres.2007.07.034 (Pubitemid 47404533)
30. Marshall J. S., Mast-cell responses to pathogens. Nature Reviews Immunology 2004 4 10 787 799 2-s2.0-5044238408 10.1038/nri1460 (Pubitemid 39336295)
31. Galli S. J., Nakae S., Tsai M., Mast cells in the development of adaptive immune responses. Nature Immunology 2005 6 2 135 142 2-s2.0-13944249962 10.1038/ni1158 (Pubitemid 40268194)
32. McCurdy J. D., Lin T.-J., Marshall J. S., Toll-like receptor 4-mediated activation of murine mast cells. Journal of Leukocyte Biology 2001 70 6 977 984 2-s2.0-0035216122 (Pubitemid 33151136)
33. Supajatura V., Ushio H., Nakao A., Okumura K., Ra C., Ogawa H., Protective roles of mast cells against enterobacterial infection are mediated by Toll-like receptor 4. Journal of Immunology 2001 167 4 2250 2256 2-s2.0-0035881267 (Pubitemid 32747537)
34. Masuda A., Yoshikai Y., Aiba K., Matsuguchi T., Th2 cytokine production from mast cells is directly induced by lipopolysaccharide and distinctly regulated by c-Jun N-terminal kinase and p38 pathways. Journal of Immunology 2002 169 7 3801 3810 2-s2.0-0036784644
35. Matsushima H., Yamada N., Matsue H., Shimada S., TLR3-, TLR7-, and TLR9-mediated production of proinflammatory cytokines and chemokines from murine connective tissue type skin-derived mast cells but not from bone marrow-derived mast cells. Journal of Immunology 2004 173 1 531 541 2-s2.0-2942731608 (Pubitemid 38797381)
36. Mrabet-Dahbi S., Metz M., Dudeck A., Zuberbier T., Maurer M., Murine mast cells secrete a unique profile of cytokines and prostaglandins in response to distinct TLR2 ligands. Experimental Dermatology 2009 18 5 437 444 2-s2.0-65249185481 10.1111/j.1600-0625.2009.00878.x
37. Varadaradjalou S., Féger F., Thieblemont N., Hamouda N. B., Pleau J.-M., Dy M., Arock M., Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells. European Journal of Immunology 2003 33 4 899 906 2-s2.0-0038744604 10.1002/eji.200323830 (Pubitemid 36546677)
38. Kulka M., Alexopoulou L., Flavell R. A., Metcalfe D. D., Activation of mast cells by double-stranded RNA: Evidence for activation through Toll-like receptor 3. Journal of Allergy and Clinical Immunology 2004 114 1 174 182 2-s2.0-3442875541 10.1016/j.jaci.2004.03.049 (Pubitemid 39005135)
39. Yoshioka M., Fukuishi N., Iriguchi S., Ohsaki K., Yamanobe H., Inukai A., Kurihara D., Imajo N., Yasui Y., Matsui N., Tsujita T., Ishii A., Seya T., Takahama M., Akagi M., Lipoteichoic acid downregulates Fc ε RI expression on human mast cells through Toll-like receptor 2. Journal of Allergy and Clinical Immunology 2007 120 2 452 461 2-s2.0-34547128872 10.1016/j.jaci.2007. 03.027 (Pubitemid 47102373)
40. Leal-Berumen I., Conlon P., Marshall J. S., IL-6 production by rat peritoneal mast cells is not necessarily preceded by histamine release and can be induced by bacterial lipopolysaccharide. Journal of Immunology 1994 152 11 5468 5476 2-s2.0-0028303731 (Pubitemid 24152996)
41. Zhu F.-G., Marshall J. S., CpG-containing oligodeoxynucleotides induce TNF- α and IL-6 production but not degranulation from murine bone marrow-derived mast cells. Journal of Leukocyte Biology 2001 69 2 253 262 2-s2.0-0035109939 (Pubitemid 32163438)
42. Orinska Z., Bulanova E., Budagian V., Metz M., Maurer M., Bulfone-Paus S., TLR3-induced activation of mast cells modulates CD8+ T-cell recruitment. Blood 2005 106 3 978 987 2-s2.0-23044508834 10.1182/blood-2004-07-2656 (Pubitemid 41076443)
43. Heib V., Becker M., Warger T., Rechtsteiner G., Tertilt C., Klein M., Bopp T., Taube C., Schild H., Schmitt E., Stassen M., Mast cells are crucial for early inflammation, migration of Langerhans cells, and CTL responses following topical application of TLR7 ligand in mice. Blood 2007 110 3 946 953 2-s2.0-34547949557 10.1182/blood-2006-07-036889 (Pubitemid 47267433)
44. Kulka M., Metcalfe D. D., TLR3 activation inhibits human mast cell attachment to fibronectin and vitronectin. Molecular Immunology 2006 43 10 1579 1586 2-s2.0-33644529703 10.1016/j.molimm.2005.09.019
45. Wierzbicki M., Brzezińska-Blłaszczyk E., Diverse effects of bacterial cell wall components on mast cell degranulation, cysteinyl leukotriene generation and migration. Microbiology and Immunology 2009 53 12 694 703 2-s2.0-75749144291 10.1111/j.1348-0421.2009.00174.x
46. Secor V. H., Secor W. E., Gutekunst C.-A., Brown M. A., Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. Journal of Experimental Medicine 2000 191 5 813 821 2-s2.0-0034610971 10.1084/jem.191.5.813
47. Sayed B. A., Walker M. E., Brown M. A., Cutting edge: mast cells regulate disease severity in a relapsing-remitting model of multiple sclerosis. Journal of Immunology 2011 186 6 3294 3298 2-s2.0-79953176981 10.4049/jimmunol.1003574
48. Tunçel N., Şener E., Cerit C., Karasu U., Gürer F., Şahintürk V., Bayçu C., Ak D., Filiz Z., Brain mast cells and therapeutic potential of vasoactive intestinal peptide in a Parkinson's disease model in rats: brain microdialysis, behavior, and microscopy. Peptides 2005 26 5 827 836 2-s2.0-16244390250 10.1016/j.peptides.2004.12.019 (Pubitemid 40461664)
49. Graves M. C., Fiala M., Dinglasan L. A. V., Liu N. Q., Sayre J., Chiappelli F., van Kooten C., Vinters H. V., Inflammation in amyotrophic lateral sclerosis spinal cord and brain is mediated by activated macrophages, mast cells and t cells. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 2004 5 4 213 219 2-s2.0-12344310088 10.1080/14660820410020286 (Pubitemid 40125187)
50. Fiala M., Chattopadhay M., La Cava A., Tse E., Liu G., Lourenco E., Eskin A., Liu P. T., Magpantay L., Tse S., Mahanian M., Weitzman R., Tong J., Nguyen C., Cho T., Koo P., Sayre J., Martinez-Maza O., Rosenthal M. J., Wiedau-Pazos M., IL-17A is increased in the serum and in spinal cord CD8 and mast cells of ALS patients. Journal of Neuroinflammation 2010 7, article 76 2-s2.0-78049519396 10.1186/1742-2094-7-76
51. Kvetnoi I. M., Kvetnaya T. V., Ryadnova I. Y., Fursov B. B., Ernandes-Jago J., Blesa J. R., Expression of β -amyloid and tau-protein in mastocytes in Alzheimer's disease. Arkhiv Patologii 2003 65 1 36 39 2-s2.0-0042161510 (Pubitemid 38880820)
52. Lozada A., Maegele M., Stark H., Neugebauert E. M. A., Panula P., Traumatic brain injury results in mast cell increase and changes in regulation of central histamine receptors. Neuropathology and Applied Neurobiology 2005 31 2 150 162 2-s2.0-15944365107 10.1111/j.1365-2990.2004.00622.x (Pubitemid 40444916)
53. Strbian D., Karjalainen-Lindsberg M.-L., Tatlisumak T., Lindsberg P. J., Cerebral mast cells regulate early ischemic brain swelling and neutrophil accumulation. Journal of Cerebral Blood Flow and Metabolism 2006 26 5 605 612 2-s2.0-33646364345 10.1038/sj.jcbfm.9600228
54. Strbian D., Tatlisumak T., Ramadan U. A., Lindsberg P. J., Mast cell blocking reduces brain edema and hematoma volume and improves outcome after experimental intracerebral hemorrhage. Journal of Cerebral Blood Flow and Metabolism 2007 27 4 795 802 2-s2.0-33947579557 10.1038/sj.jcbfm.9600387 (Pubitemid 46476784)
55. Mokhtarian F., Griffin D. E., The role of mast cells in virus-induced inflammation in the murine central nervous system. Cellular Immunology 1984 86 2 491 500 2-s2.0-0021266848 (Pubitemid 14085283)
56. Brenner T., Soffer D., Shalit M., Levi-Schaffer F., Mast cells in experimental allergic encephalomyelitis: Characterization, distribution in the CNS and in vitro activation by myelin basic protein and neuropeptides. Journal of the Neurological Sciences 1994 122 2 210 213 2-s2.0-0028221619 10.1016/0022-510X(94)90300-X (Pubitemid 24097271)
57. Johnson D., Seeldrayers P. A., Weiner H. L., The role of mast cells in demyelination. 1. Myelin proteins are degraded by mast cell proteases and myelin basic protein and P2 can stimulate mast cell degranulation. Brain Research 1988 444 1 195 198 2-s2.0-0023879370 (Pubitemid 18071210)
58. Napoli I., Neumann H., Microglial clearance function in health and disease. Neuroscience 2009 158 3 1030 1038 2-s2.0-59349112140 10.1016/j.neuroscience.2008.06.046
59. Ribes S., Adam N., Ebert S., Regen T., Bunkowski S., Hanisch U.-K., Nau R., The viral TLR3 agonist poly(I:C) stimulates phagocytosis and intracellular killing of Escherichia coli by microglial cells. Neuroscience Letters 2010 482 1 17 20 2-s2.0-77955554892 10.1016/j.neulet.2010.06.078
60. Venero J. L., Burguillos M. A., Brundin P., Joseph B., The executioners sing a new song: Killer caspases activate microglia. Cell Death and Differentiation 2011 18 11 1679 1691 2-s2.0-81155161863 10.1038/cdd.2011.107
61. Kees T., Lohr J., Noack J., Mora R., Gdynia G., Tödt G., Ernst A., Radlwimmer B., Falk C. S., Herold-Mende C., Régnier-Vigouroux A., Microglia isolated from patients with glioma gain antitumor activities on poly (I:C) stimulation. Neuro-Oncology 2012 14 1 64 78 2-s2.0-84856292648 10.1093/neuonc/nor182
62. Wang T., Town T., Alexopoulou L., Anderson J. F., Fikrig E., Flavell R. A., Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nature Medicine 2004 10 12 1366 1373 2-s2.0-11144273976 10.1038/nm1140 (Pubitemid 40022719)
63. Supajatura V., Ushio H., Nakao A., Akira S., Okumura K., Ra C., Ogawa H., Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. Journal of Clinical Investigation 2002 109 10 1351 1359 2-s2.0-0036105543 10.1172/JCI200214704 (Pubitemid 34546900)
64. Kubo Y., Fukuishi N., Yoshioka M., Kawasoe Y., Iriguchi S., Imajo N., Yasui Y., Matsui N., Akagi M., Bacterial components regulate the expression of Toll-like receptor 4 on human mast cells. Inflammation Research 2007 56 2 70 75 2-s2.0-33947107565 10.1007/s00011-006-6064-4 (Pubitemid 46412011)
65. Nigo Y. I., Yamashita M., Hirahara K., Shinnakasu R., Inami M., Kimura M., Hasegawa A., Kohno Y., Nakayama T., Regulation of allergic airway inflammation through Toll-like receptor 4-mediated modification of mast cell function. Proceedings of the National Academy of Sciences of the United States of America 2006 103 7 2286 2291 2-s2.0-33144468160 10.1073/pnas.0510685103 (Pubitemid 43271662)
66. Feuser K., Thon K.-P., Bischoff S. C., Lorentz A., Human intestinal mast cells are a potent source of multiple chemokines. Cytokine 2012 58 2 178 185 2-s2.0-84859217123 10.1016/j.cyto.2012.01.001
67. Skaper S. D., Giusti P., Facci L., Microglia and mast cells: Two tracks on the road to neuroinflammation. The FASEB Journal 2012 26 3103 3117
68. Rozniecki J. J., Hauser S. L., Stein M., Lincoln R., Theoharides T. C., Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients. Annals of Neurology 1995 37 1 63 66 2-s2.0-0028908819 10.1002/ana.410370112
69. Malamud V., Vaaknin A., Abramsky O., Mor M., Burgess L. E., Ben-Yehudah A., Lorberboum-Galski H., Tryptase activates peripheral blood mononuclear cells causing the synthesis and release of TNF- α IL-6 and IL-1 β: Possible relevance to multiple sclerosis. Journal of Neuroimmunology 2003 138 1-2 115 122 2-s2.0-0037960323 10.1016/S0165-5728(03)00090-0 (Pubitemid 36566425)
70. Ossovskaya V. S., Bunnett N. W., Protease-activated receptors: Contribution to physiology and disease. Physiological Reviews 2004 84 2 579 621 2-s2.0-1642279517 10.1152/physrev.00028.2003 (Pubitemid 38365493)
71. Molino M., Barnathan E. S., Numerof R., Clark J., Dreyer M., Cumashi A., Hoxie J. A., Schechter N., Woolkalis M., Brass L. F., Interactions of mast cell tryptase with thrombin receptors and PAR-2. Journal of Biological Chemistry 1997 272 7 4043 4049 2-s2.0-15444346942 10.1074/jbc.272.7.4043 (Pubitemid 27078466)
72. Olejár T., Matěj R., Zadinová M., Poučková P., Proteinase-activated receptor-2 expression on cerebral neurones after radiation damage: Immunohistochemical observation in Wistar rats. International Journal of Tissue Reactions 2002 24 3 81 88 2-s2.0-0036910597 (Pubitemid 36292238)
73. Rohatgi T., Henrich-Noack P., Sedehizade F., Goertler M., Wallesch C. W., Reymann K. G., Reiser G., Transient focal ischemia in rat brain differentially regulates mRNA expression of protease-activated receptors 1 to 4. Journal of Neuroscience Research 2004 75 2 273 279 2-s2.0-0346099092 10.1002/jnr.10847 (Pubitemid 38049398)
74. Jin Y., Silverman A. J., Vannucci S. J., Mast cells are early responders after hypoxia-ischemia in immature rat brain. Stroke 2009 40 9 3107 3112 2-s2.0-70349237576 10.1161/STROKEAHA.109.549691
75. Hagberg H., Peebles D., Mallard C., Models of white matter injury: Comparison of infectious, hypoxic-Ischemic, and excitotoxic insults. Mental Retardation and Developmental Disabilities Research Reviews 2002 8 1 30 38 2-s2.0-0036309487 10.1002/mrdd.10007 (Pubitemid 34754491)
76. Pang Y., Cai Z., Rhodes P. G., Disturbance of oligodendrocyte development, hypomyelination and white matter injury in the neonatal rat brain after intracerebral injection of lipopolysaccharide. Developmental Brain Research 2003 140 2 205 214 2-s2.0-0037448744 10.1016/S0165-3806(02)00606-5 (Pubitemid 36173978)
77. Dean J. M., Wang X., Kaindl A. M., Gressens P., Fleiss B., Hagberg H., Mallard C., Microglial MyD88 signaling regulates acute neuronal toxicity of LPS-stimulated microglia in vitro. Brain, Behavior, and Immunity 2010 24 776 783 10.1016/j.bbi.2009.10.018
78. Lehnard S., Lachance C., Patrizi S., Lefebvre S., Follett P. L., Jensen F. E., Rosenberg P. A., Volpe J. J., Vartanian T., The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. Journal of Neuroscience 2002 22 7 2478 2486 2-s2.0-0036548360 (Pubitemid 37465796)
79. Farina C., Aloisi F., Meinl E., Astrocytes are active players in cerebral innate immunity. Trends in Immunology 2007 28 3 138 145 2-s2.0-33847099936 10.1016/j.it.2007.01.005 (Pubitemid 46283692)
80. Carpentier P. A., Begolka W. S., Olson J. K., Elhofy A., Karpus W. J., Miller S. D., Differential activation of astrocytes by innate and adaptive immune stimuli. Glia 2005 49 3 360 374 2-s2.0-13544272944 10.1002/glia.20117 (Pubitemid 40222914)
81. Scumpia P. O., Kelly K. M., Reeves W. H., Stevens B. R., Double-stranded RNA signals antiviral and inflammatory programs and dysfunctional glutamate transport in TLR3-expressing astrocytes. Glia 2005 52 2 153 162 2-s2.0-27844507557 10.1002/glia.20234 (Pubitemid 41652919)
82. Kim H., Yang E., Lee J., Kim S.-H., Shin J.-S., Park J. Y., Choi S. J., Kim S. J., Choi I.-H., Double-stranded RNA mediates interferon regulatory factor 3 activation and interleukin-6 production by engaging Toll-like receptor 3 in human brain astrocytes. Immunology 2008 124 4 480 488 2-s2.0-46949108148 10.1111/j.1365-2567.2007.02799.x (Pubitemid 351962544)
83. Bsibsi M., Persoon-Deen C., Verwer R. W. H., Meeuwsen S., Ravid R., Van Noort J. M., Toll-like receptor 3 on adult human astrocytes triggers production of neuroprotective mediators. Glia 2006 53 7 688 695 2-s2.0-33646258023 10.1002/glia.20328
84. Hanke M. L., Kielian T., Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential. Clinical Science 2011 121 9 367 387 2-s2.0-80052315340 10.1042/CS20110164
85. Caso J. R., Pradillo J. M., Hurtado O., Lorenzo P., Moro M. A., Lizasoain I., Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke. Circulation 2007 115 12 1599 1608 2-s2.0-34247545017 10.1161/CIRCULATIONAHA.106.603431 (Pubitemid 46648645)
86. Tang S.-C., Arumugam T. V., Xu X., Cheng A., Mughal M. R., Dong G. J., Lathia J. D., Siler D. A., Chigurupati S., Ouyang X., Magnus T., Camandola S., Mattson M. P., Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proceedings of the National Academy of Sciences of the United States of America 2007 104 34 13798 13803 2-s2.0-35348860696 10.1073/pnas.0702553104 (Pubitemid 350003400)
87. Kilic U., Kilic E., Matter C. M., Bassetti C. L., Hermann D. M., TLR-4 deficiency protects against focal cerebral ischemia and axotomy-induced neurodegeneration. Neurobiology of Disease 2008 31 1 33 40 2-s2.0-45049087782 10.1016/j.nbd.2008.03.002
88. Cashman J. R., Ghirmai S., Abel K. J., Fiala M., Immune defects in Alzheimer's disease: New medications development. BMC Neuroscience 2008 9 2, article S13 2-s2.0-57449111231 10.1186/1471-2202-9-S2-S13
89. Tang S.-C., Lathia J. D., Selvaraj P. K., Jo D.-G., Mughal M. R., Cheng A., Siler D. A., Markesbery W. R., Arumugam T. V., Mattson M. P., Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid β -peptide and the membrane lipid peroxidation product 4-hydroxynonenal. Experimental Neurology 2008 213 1 114 121 2-s2.0-49349097868 10.1016/j.expneurol.2008.05.014
90. Marta M., Toll-like receptors in multiple sclerosis mouse experimental models. Annals of the New York Academy of Sciences 2009 1173 458 462 2-s2.0-69949184869 10.1111/j.1749-6632.2009.04849.x
91. Gorina R., Font-Nieves M., Márquez-Kisinousky L., Santalucia T., Planas A. M., Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88-dependent NF B signaling, MAPK, and Jak1/Stat1 pathways. GLIA 2011 59 2 242 255 2-s2.0-78650250592 10.1002/glia.21094
92. Jack C. S., Arbour N., Manusow J., Montgrain V., Blain M., McCrea E., Shapiro A., Antel J. P., TLR signaling tailors innate immune responses in human microglia and astrocytes. Journal of Immunology 2005 175 7 4320 4330 2-s2.0-25444498280 (Pubitemid 41361966)
93. Krasowska-Zoladek A., Banaszewska M., Kraszpulski M., Konat G. W., Kinetics of inflammatory response of astrocytes induced by TLR3 and TLR4 ligation. Journal of Neuroscience Research 2007 85 1 205 212 2-s2.0-33846146647 10.1002/jnr.21088 (Pubitemid 46079810)
94. Bsibsi M., Ravid R., Gveric D., Van Noort J. M., Broad expression of Toll-like receptors in the human central nervous system. Journal of Neuropathology and Experimental Neurology 2002 61 11 1013 1021 2-s2.0-0036841178 (Pubitemid 35278723)
95. Setzu A., Lathia J. D., Zhao C., Wells K., Rao M. S., Ffrench-Constant C., Franklin R. J. M., Inflammation stimulates myelination by transplanted oligodendrocyte precursor cells. Glia 2006 54 4 297 303 2-s2.0-33748143936 10.1002/glia.20371 (Pubitemid 44316234)
96. Kigerl K. A., Lai W., Rivest S., Hart R. P., Satoskar A. R., Popovich P. G., Toll-like receptor (TLR)-2 and TLR-4 regulate inflammation, gliosis, and myelin sparing after spinal cord injury. Journal of Neurochemistry 2007 102 1 37 50 2-s2.0-34250182782 10.1111/j.1471-4159.2007.04524.x (Pubitemid 46906264)
97. Sharma R., Fischer M.-T., Bauer J., Felts P. A., Smith K. J., Misu T., Fujihara K., Bradl M., Lassmann H., Inflammation induced by innate immunity in the central nervous system leads to primary astrocyte dysfunction followed by demyelination. Acta Neuropathologica 2010 120 2 223 236 2-s2.0-77957275551 10.1007/s00401-010-0704-z
98. Schonberg D. L., Popovich P. G., McTigue D. M., Oligodendrocyte generation is differentially influenced by toll-like receptor (TLR) 2 and TLR4-mediated intraspinal macrophage activation. Journal of Neuropathology and Experimental Neurology 2007 66 12 1124 1135 2-s2.0-37349130280 10.1097/nen.0b013e31815c2530 (Pubitemid 350294662)
99. Glezer I., Lapointe A., Rivest S., Innate immunity triggers oligodendrocyte progenitor reactivity and confines damages to brain injuries. The FASEB Journal 2006 20 6 750 752 2-s2.0-33646251131 10.1096/fj.05-5234fje (Pubitemid 46671203)
100. Bsibsi M., Nomden A., van Noort J. M., Baron W., Toll-like receptors 2 and 3 agonists differentially affect oligodendrocyte survival, differentiation, and myelin membrane formation. Journal of Neuroscience Research 2012 90 2 388 398 2-s2.0-83155175197 10.1002/jnr.22767
101. Lehnardt S., Massillon L., Follett P., Jensen F. E., Ratan R., Rosenberg P. A., Volpe J. J., Vartanian T., Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proceedings of the National Academy of Sciences of the United States of America 2003 100 14 8514 8519 2-s2.0-0037477629 10.1073/pnas.1432609100 (Pubitemid 36842576)
102. Felts P. A., Woolston A.-M., Fernando H. B., Asquith S., Gregson N. A., Mizzi O. J., Smith K. J., Inflammation and primary demyelination induced by the intraspinal injection of lipopolysaccharide. Brain 2005 128 7 1649 1666 2-s2.0-21944442728 10.1093/brain/awh516 (Pubitemid 41373684)
103. Li J., Ramenaden E. R., Peng J., Koito H., Volpe J. J., Rosenberg P. A., Tumor necrosis factor α mediates lipopolysaccharide-induced microglial toxicity to developing oligodendrocytes when astrocytes are present. Journal of Neuroscience 2008 28 20 5321 5330 2-s2.0-45549099573 10.1523/JNEUROSCI.3995-07. 2008
104. Kim S., Steelman A. J., Koito H., Li J., Astrocytes promote TNF-mediated toxicity to oligodendrocyte precursors. Journal of Neurochemistry 2011 116 1 53 66 2-s2.0-78650142749 10.1111/j.1471-4159.2010.07084.x
105. Steelman A. J., Li J., Poly(I:C) promotes TNF α /TNFR1-dependent oligodendrocyte death in mixed glial cultures. Journal of Neuroinflammation 2011 8, article 89 2-s2.0-79960996832 10.1186/1742-2094-8-89
106. Sternberg E. M., Neural regulation of innate immunity: A coordinated nonspecific host response to pathogens. Nature Reviews Immunology 2006 6 4 318 328 2-s2.0-33645284772 10.1038/nri1810
107. Gomariz R. P., Gutiérrez-Cañas I., Arranz A., Carrión M., Juarranz Y., Leceta J., Martínez C., Peptides targeting toll-like receptor signalling pathways for novel immune therapeutics. Current Pharmaceutical Design 2010 16 9 1063 1080 2-s2.0-77950199408 10.2174/138161210790963841
108. Ben-Sasson S. Z., Caucheteux S., Crank M., Hu-Li J., Paul W. E., IL-1 acts on T cells to enhance the magnitude of in vivo immune responses. Cytokine 2011 56 1 122 125 2-s2.0-80052776071 10.1016/j.cyto.2011.07.006
109. Kanneganti T.-D., Central roles of NLRs and inflammasomes in viral infection. Nature Reviews Immunology 2010 10 10 688 698 2-s2.0-77957228318 10.1038/nri2851
110. Gross O., Thomas C. J., Guarda G., Tschopp J., The inflammasome: An integrated view. Immunological Reviews 2011 243 1 136 151 2-s2.0-80052164574 10.1111/j.1600-065X.2011.01046.x
111. Pétrilli V., Papin S., Dostert C., Mayor A., Martinon F., Tschopp J., Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death and Differentiation 2007 14 9 1583 1589 2-s2.0-34548027736 10.1038/sj.cdd.4402195 (Pubitemid 47278844)
112. Dostert C., Pétrilli V., Van Bruggen R., Steele C., Mossman B. T., Tschopp J., Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008 320 5876 674 677 2-s2.0-43249125839 10.1126/science.1156995 (Pubitemid 351928351)
113. Craven R. R., Gao X., Allen I. C., Gris D., Wardenburg J. B., McElvania-TeKippe E., Ting J. P., Duncan J. A., Staphylococcus aureus α -hemolysin activates the NLRP3-inflammasome in human and mouse monocytic cells. PLoS ONE 2009 4 10 2-s2.0-70449360107 10.1371/journal.pone.0007446 e7446
114. Mariathasan S., Weiss D. S., Newton K., McBride J., O'Rourke K., Roose-Girma M., Lee W. P., Weinrauch Y., Monack D. M., Dixit V. M., Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006 440 7081 228 232 2-s2.0-32944470765 10.1038/nature04515 (Pubitemid 43372102)
115. Sutterwala F. S., Ogura Y., Szczepanik M., Lara-Tejero M., Lichtenberger G. S., Grant E. P., Bertin J., Coyle A. J., Galán J. E., Askenase P. W., Flavell R. A., Critical role for NALP3/CIAS1/cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 2006 24 3 317 327 2-s2.0-33644985564 10.1016/j.immuni.2006.02.004
116. Pelegrin P., Surprenant A., Pannexin-1 mediates large pore formation and interleukin-1 β release by the ATP-gated P2X7 receptor. The EMBO Journal 2006 25 21 5071 5082 2-s2.0-33750473352 10.1038/sj.emboj.7601378 (Pubitemid 44658525)
117. Locovei S., Wang J., Dahl G., Activation of pannexin 1 channels by ATP through P2Y receptors and by cytoplasmic calcium. FEBS Letters 2006 580 1 239 244 2-s2.0-29344452180 10.1016/j.febslet.2005.12.004 (Pubitemid 43005343)
118. Kanneganti T.-D., Lamkanfi M., Kim Y.-G., Chen G., Park J.-H., Franchi L., Vandenabeele P., Núñez G., Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of Toll-like receptor signaling. Immunity 2007 26 4 433 443 2-s2.0-34247118826 10.1016/j.immuni.2007.03.008 (Pubitemid 46603000)
119. Silverman W. R., de Rivero Vaccari J. P., Locovei S., Qiu F., Carlsson S. K., Scemes E., Keane R. W., Dahl G., The pannexin 1 channel activates the inflammasome in neurons and astrocytes. Journal of Biological Chemistry 2009 284 27 18143 18151 2-s2.0-67650546999 10.1074/jbc.M109.004804
120. Sáez J. C., Schalper K. A., Retamal M. A., Orellana J. A., Shoji K. F., Bennett M. V. L., Cell membrane permeabilization via connexin hemichannels in living and dying cells. Experimental Cell Research 2010 316 15 2377 2389 2-s2.0-77955087401 10.1016/j.yexcr.2010.05.026
121. Bennett M. V. L., Contreras J. E., Bukauskas F. F., Sáez J. C., New roles for astrocytes: gap junction hemichannels have something to communicate. Trends in Neurosciences 2003 26 11 610 617 2-s2.0-0242380301 10.1016/j.tins.2003.09.008 (Pubitemid 37338369)
122. Sáez J. C., Retamal M. A., Basilio D., Bukauskas F. F., Bennett M. V. L., Connexin-based gap junction hemichannels: gating mechanisms. Biochimica et Biophysica Acta 2005 1711 2 215 224 2-s2.0-20444413024 10.1016/j.bbamem.2005. 01.014 (Pubitemid 40799296)
123. Thornton P., Pinteaux E., Gibson R. M., Allan S. M., Rothwell N. J., Interleukin-1-induced neurotoxicity is mediated by glia and requires caspase activation and free radical release. Journal of Neurochemistry 2006 98 1 258 266 2-s2.0-33745096234 10.1111/j.1471-4159.2006.03872.x (Pubitemid 43882950)
124. Orellana J. A., Sáez P. J., Shoji K. F., Schalper K. A., Palacios-Prado N., Velarde V., Giaume C., Bennett M. V. L., Sáez J. C., Modulation of brain hemichannels and gap junction channels by pro-inflammatory agents and their possible role in neurodegeneration. Antioxidants and Redox Signaling 2009 11 2 369 399 2-s2.0-58149100746 10.1089/ars.2008.2130
125. Orellana J. A., Froger N., Ezan P., Jiang J. X., Bennett M. V. L., Naus
126. Orellana J. A., Shoji K. F., Abudara V., Ezan P., Amigou E., Sáez P. J., Jiang J. X., Naus C. C., Sáez J. C., Giaume C., Amyloid β -induced death in neurons involves glial and neuronal hemichannels. Journal of Neuroscience 2011 31 13 4962 4977 2-s2.0-79955739803 10.1523/JNEUROSCI.6417-10. 2011
127. Vliagoftis H., Hutson A. M., Mahmudi-Azer S., Kim H., Rumsaeng V., Oh C. K., Moqbel R., Metcalfe D. D., Mast cells express connexins on their cytoplasmic membrane. Journal of Allergy and Clinical Immunology 1999 103 4 656 662 2-s2.0-0032984070 10.1016/S0091-6749(99)70239-3 (Pubitemid 29295574)
128. Tatham P. E. R., Lindau M., ATP-induced pore formation in the plasma membrane of rat peritoneal mast cells. Journal of General Physiology 1990 95 3 459 476 2-s2.0-0025274812 (Pubitemid 20109759)
129. Parekh A. B., Putney J. W. Jr., Store-operated calcium channels. Physiological Reviews 2005 85 2 757 810 2-s2.0-15544368216 10.1152/physrev. 00057.2003 (Pubitemid 40404641)
130. Ponomarev E. D., Shriver L. P., Maresz K., Dittel B. N., Microglial cell activation and proliferation precedes the onset of CNS autoimmunity. Journal of Neuroscience Research 2005 81 3 374 389 2-s2.0-25444484079 10.1002/jnr.20488 (Pubitemid 41359292)
131. Ponomarev E. D., Shriver L. P., Dittel B. N., CD40 expression by microglial cells is required for their completion of a two-step activation process during central nervous system autoimmune inflammation. Journal of Immunology 2006 176 3 1402 1410 2-s2.0-31144457903 (Pubitemid 43134282)
132. Chen K., Huang J., Gong W., Zhang L., Yu P., Wang J. M., CD40/CD40L dyad in the inflammatory and immune responses in the central nervous system. Cellular & Molecular Immunology 2006 3 3 163 169 2-s2.0-34248360349
133. Graeber M. B., Streit W. J., Microglia: biology and pathology. Acta Neuropathologica 2010 119 1 89 105 2-s2.0-77649184973 10.1007/s00401-009-0622-0
134. Polazzi E., Contestabile A., Overactivation of LPS-stimulated microglial cells by co-cultured neurons or neuron-conditioned medium. Journal of Neuroimmunology 2006 172 1-2 104 111 2-s2.0-33244460315 10.1016/j.jneuroim.2005. 11.005 (Pubitemid 43277495)
135. Bennett M. V., Garre J. M., Orellana J. A., Bukauskas F. F., Nedergaard M., Saez J. C., Connexin and pannexin hemichannels in inflammatory responses of glia and neurons. Brain Research 2012 1487 3 15
136. Eugenín E. A., Eckardt D., Theis M., Willecke K., Bennett M. V. L., Sáez J. C., Microglia at brain stab wounds express connexin 43 and in vitro form functional gap junctions after treatment with interferon- γ and tumor necrosis factor- α Proceedings of the National Academy of Sciences of the United States of America 2001 98 7 4190 4195 2-s2.0-0035957352 10.1073/pnas.051634298 (Pubitemid 32249920)
137. Parenti R., Campisi A., Vanella A., Cicirata F., Immunocytochemical and RT-PCR analysis of connexin36 in cultures of mammalian glial cells. Archives Italiennes de Biologie 2002 140 2 101 108 2-s2.0-0036207478 (Pubitemid 34251860)
138. Dobrenis K., Chang H.-Y., Pina-Benabou M. H., Woodroffe A., Lee S. C., Rozental R., Spray D. C., Scemes E., Human and mouse microglia express connexin36, and functional gap junctions are formed between rodent microglia and neurons. Journal of Neuroscience Research 2005 82 3 306 315 2-s2.0-27644524673 10.1002/jnr.20650 (Pubitemid 41552482)
139. Garg S., Syed M. M., Kielian T., Staphylococcus aureus-derived peptidoglycan induces Cx43 expression and functional gap junction intercellular communication in microglia. Journal of Neurochemistry 2005 95 2 475 483 2-s2.0-26844515789 10.1111/j.1471-4159.2005.03384.x (Pubitemid 41457516)
140. Martinez A. D., Hayrapetyan V., Moreno A. P., Beyer E. C., Connexin43 and connexin45 form heteromeric gap junction channels in which individual components determine permeability and regulation. Circulation Research 2002 90 10 1100 1107 2-s2.0-0037205321 10.1161/01.RES.0000019580.64013.31 (Pubitemid 34627909)
141. Giaume C., McCarthy K. D., Control of gap-junctional communication in astrocytic networks. Trends in Neurosciences 1996 19 8 319 325 2-s2.0-0030221740 10.1016/0166-2236(96)10046-1 (Pubitemid 26349060)
142. Scemes E., Giaume C., Astrocyte calcium waves: what they are and what they do. Glia 2006 54 7 716 725 2-s2.0-33750368810 10.1002/glia.20374 (Pubitemid 44629634)
143. Cotrina M. L., Lin J. H.-C., López-García J. C., Naus C. C. G., Nedergaard M., ATP-mediated glia signaling. Journal of Neuroscience 2000 20 8 2835 2844 2-s2.0-0034656086 (Pubitemid 30220308)
144. Calegari F., Coco S., Taverna E., Bassetti M., Verderio C., Corradi N., Matteoli M., Rosa P., A regulated secretory pathway in cultured hippocampal astrocytes. Journal of Biological Chemistry 1999 274 32 22539 22547 2-s2.0-0033529646 10.1074/jbc.274.32.22539 (Pubitemid 29379296)
145. Stout C., Charles A., Modulation of intercellular calcium signaling in astrocytes by extracellular calcium and magnesium. Glia 2003 43 3 265 273 2-s2.0-0042364995 10.1002/glia.10257 (Pubitemid 37047682)
146. Kang J., Kang N., Lovatt D., Torres A., Zhao Z., Lin J., Nedergaard M., Connexin 43 hemichannels are permeable to ATP. Journal of Neuroscience 2008 28 18 4702 4711 2-s2.0-44649092806 10.1523/JNEUROSCI.5048-07.2008
147. Iglesias R., Dahl G., Qiu F., Spray D. C., Scemes E., Pannexin 1: The molecular substrate of astrocyte "hemichannels" Journal of Neuroscience 2009 29 21 7092 7097 2-s2.0-66149173401 10.1523/JNEUROSCI.6062-08. 2009
148. Parpura V., Basarsky T. A., Liu F., Jeftinija K., Jeftinija S., Haydon P. G., Glutamate-mediated astrocyte-neuron signalling. Nature 1994 369 6483 744 747 2-s2.0-0028225677 10.1038/369744a0 (Pubitemid 24225363)
149. Albrecht J., Rafalowska U., Enhanced potassium-stimulated γ -aminobutyric acid release by astrocytes derived from rats with early hepatogenic encephalopathy. Journal of Neurochemistry 1987 49 1 9 11 2-s2.0-0023197144 (Pubitemid 17108223)
150. Queiroz G., Gebicke-Haerter P. J., Schobert A., Starke K., Von Kügelgen I., Release of ATP from cultured rat astrocytes elicited by glutamate receptor activation. Neuroscience 1997 78 4 1203 1208 2-s2.0-0030950658 10.1016/S0306-4522(96)00637-9 (Pubitemid 27223722)
151. Albrecht J., Simmons M., Dutton G. R., Norenberg M. D., Aluminium chloride stimulates the release of endogenous glutamate, taurine and adenosine from cultured rat cortical astrocytes. Neuroscience Letters 1991 127 1 105 107 2-s2.0-0025922307 10.1016/0304-3940(91)90905-9
152. Stehberg J., Moraga-Amaro R., Salazar C., Becerra A., Echeverria C., Orellana J. A., Bultynck G., Ponsaerts R., Leybaert L., Simon F., Saez J. C., Retamal M. A., Release of gliotransmitters through astroglial connexin 43 hemichannels is necessary for fear memory consolidation in the basolateral amygdala. The FASEB Journal 2012 26 3649 3657
153. Nagy J. I., Ionescu A.-V., Lynn B. D., Rash J. E., Coupling of astrocyte connexins Cx26, Cx30, Cx43 to oligodendrocyte Cx29, Cx32, Cx47: Implications from normal and connexin32 knockout mice. Glia 2003 44 3 205 218 2-s2.0-0344876141 10.1002/glia.10278 (Pubitemid 37484472)
154. Retamal M. A., Froger N., Palacios-Prado N., Ezan P., Sáez P. J., Sáez J. C., Giaume C., Cx43 hemichannels and gap junction channels in astrocytes are regulated oppositely by proinflammatory cytokines released from activated microglia. Journal of Neuroscience 2007 27 50 13781 13792 2-s2.0-37249015389 10.1523/JNEUROSCI.2042-07.2007 (Pubitemid 350278255)
155. Davidson J. O., Green C. R., B. Nicholson L. F., O'Carroll S. J., Fraser M., Bennet L., Jan Gunn A., Connexin hemichannel blockade improves outcomes in a model of fetal ischemia. Annals of Neurology 2012 71 1 121 132 2-s2.0-84856153262 10.1002/ana.22654
156. Karpuk N., Burkovetskaya M., Fritz T., Angle A., Kielian T., Neuroinflammation leads to region-dependent alterations in astrocyte gap junction communication and hemichannel activity. Journal of Neuroscience 2011 31 2 414 425 2-s2.0-78651472166 10.1523/JNEUROSCI.5247-10.2011
157. Eugenin E. A., Basilio D., Sáez J. C., Orellana J. A., Raine C. S., Bukauskas F., Bennett M. V. L., Berman J. W., The role of gap junction channels during physiologic and pathologic conditions of the human central nervous system. Journal of Neuroimmune Pharmacology 2012 7 3 499 518 2-s2.0-84860126713 10.1007/s11481-012-9352-5
158. Orellana J. A., Hernández D. E., Ezan P., Velarde V., Bennett M. V. L., Giaume C., Sáez J. C., Hypoxia in high glucose followed by reoxygenation in normal glucose reduces the viability of cortical astrocytes through increased permeability of connexin 43 hemichannels. Glia 2010 58 3 329 343 2-s2.0-75849165091 10.1002/glia.20926
159. Rovegno M., Soto P. A., Sáez J. C., von Bernhardi R., Biological mechanisms involved in the spread of traumatic brain damage. Medicina Intensiva 2012 36 1 37 44 2-s2.0-84855832646 10.1016/j.medin.2011.06.008
160. Grayson B. E., Levasseur P. R., Williams S. M., Smith M. S., Marks D. L., Grove K. L., Changes in melanocortin expression and inflammatory pathways in fetal offspring of nonhuman primates fed a high-fat diet. Endocrinology 2010 151 4 1622 1632 2-s2.0-77950216899 10.1210/en.2009-1019
161. Baumann N., Pham-Dinh D., Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiological Reviews 2001 81 2 871 927 2-s2.0-0035066639 (Pubitemid 32267079)
162. Dougherty J. D., Fomchenko E. I., Akuffo A. A., Schmidt E., Helmy K. Y., Bazzoli E., Brennan C. W., Holland E. C., Milosevic A., Candidate pathways for promoting differentiation or quiescence of oligodendrocyte progenitor-like cells in glioma. Cancer Research 2012 72 4856 4868
163. Miron V. E., Kuhlmann T., Antel Jack P. J. P., Cells of the oligodendroglial lineage, myelination, and remyelination. Biochimica et Biophysica Acta 2011 1812 2 184 193 2-s2.0-78650177929 10.1016/j.bbadis.2010.09. 010
164. Magnotti L. M., Goodenough D. A., Paul D. L., Deletion of oligodendrocyte Cx32 and astrocyte Cx43 causes white matter vacuolation, astrocyte loss and early mortality. Glia 2011 59 7 1064 1074 2-s2.0-79955819402 10.1002/glia.21179
165. Nualart-Marti A., Solsona C., Fields R. D., Gap junction communication in myelinating glia. Biochimica et Biophysica Acta 2013 1828 1 69 78 2-s2.0-84857263838 10.1016/j.bbamem.2012.01.024
166. Schousboe A., Westergaard N., Sonnewald U., Petersen S. B., Huang R., Peng L., Hertz L., Glutamate and glutamine metabolism and compartmentation in astrocytes. Developmental Neuroscience 1993 15 3-5 359 366 2-s2.0-0027724955 (Pubitemid 24258171)
167. Kamasawa N., Sik A., Morita M., Yasumura T., Davidson K. G. V., Nagy J. I., Rash J. E., Connexin-47 and connexin-32 in gap junctions of oligodendrocyte somata, myelin sheaths, paranodal loops and Schmidt-Lanterman incisures: Implications for ionic homeostasis and potassium siphoning. Neuroscience 2005 136 1 65 86 2-s2.0-26944484034 10.1016/j.neuroscience.2005.08.027 (Pubitemid 41483836)
168. Bruce C. C., Zhao C., Franklin R. J. M., Remyelination-an effective means of neuroprotection. Hormones and Behavior 2010 57 1 56 62 2-s2.0-73049105525 10.1016/j.yhbeh.2009.06.004
169. Ahn M., Lee J., Gustafsson A., Enriquez A., Lancaster E., Sul J.-Y., Haydon P. G., Paul D. L., Huang Y., Abrams C. K., Scherer S. S., Cx29 and Cx32, two connexins expressed by myelinating glia, do not interact and are functionally distinct. Journal of Neuroscience Research 2008 86 5 992 1006 2-s2.0-41149103982 10.1002/jnr.21561 (Pubitemid 351441297)
170. Domercq M., Perez-Samartin A., Aparicio D., Alberdi E., Pampliega O., Matute C., P2X7 receptors mediate ischemic damage to oligodendrocytes. Glia 2010 58 6 730 740 2-s2.0-77950889709 10.1002/glia.20958
171. Brosnan C. F., Raine C. S., Mechanisms of immune injury in multiple sclerosis. Brain Pathology 1996 6 3 243 257 2-s2.0-0030056639 (Pubitemid 26246381)
172. Genain C. P., Abel K., Belmar N., Villinger F., Rosenberg D. P., Linington C., Raine C. S., Hauser S. L., Late complications of immune deviation therapy in a nonhuman primate. Science 1996 274 5295 2054 2057 2-s2.0-0030452309 10.1126/science.274.5295.2054 (Pubitemid 27020694)
173. Genain C. P., Cannella B., Hauser S. L., Raine C. S., Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nature Medicine 1999 5 2 170 175 2-s2.0-0032950794 10.1038/5532 (Pubitemid 29068523)
174. Linington C., Bradl M., Lassmann H., Brunner C., Vass K., Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. American Journal of Pathology 1988 130 3 443 454 2-s2.0-0023931606 (Pubitemid 18091372)
175. Selmaj K. W., Raine C. S., Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Annals of Neurology 1988 23 4 339 346 2-s2.0-0023904746 (Pubitemid 18098239)
176. Vartanian T., Li You L. Y., Zhao Meijuan Z. M., Stefansson K., Interferon-gamma-induced oligodendrocyte cell death: Implications for the pathogenesis of multiple sclerosis. Molecular Medicine 1995 1 7 732 743 2-s2.0-0029410743 (Pubitemid 3013083)
177. Curatolo L., Valsasina B., Caccia C., Raimondi G. L., Orsini G., Bianchetti A., Recombinant human IL-2 is cytotoxic to oligodendrocytes after in vitro self aggregation. Cytokine 1997 9 10 734 739 2-s2.0-0031258110 10.1006/cyto.1997.0228 (Pubitemid 27477716)
178. Hisahara S., Shoji S., Okano H., Miura M., ICE/CED-3 family executes oligodendrocyte apoptosis by tumor necrosis factor. Journal of Neurochemistry 1997 69 1 10 20 2-s2.0-0030942747 (Pubitemid 27274151)
179. Jurewicz A., Matysiak M., Tybor K., Kilianek L., Raine C. S., Selmaj K., Tumour necrosis factor-induced death of adult human oligodendrocytes is mediated by apoptosis inducing factor. Brain 2005 128 11 2675 2688 2-s2.0-27644510002 10.1093/brain/awh627 (Pubitemid 41552951)
180. Agresti C., Meomartini M. E., Amadio S., Ambrosini E., Volonté C., Aloisi F., Visentin S., ATP regulates oligodendrocyte progenitor migration, proliferation, and differentiation: Involvement of metabotropic P2 receptors. Brain Research Reviews 2005 48 2 157 165 2-s2.0-17844361897 10.1016/j. brainresrev.2004.12.005 (Pubitemid 40585746)
181. Merrill J. E., Scolding N. J., Mechanisms of damage to myelin and oligodendrocytes and their relevance to disease. Neuropathology and Applied Neurobiology 1999 25 6 435 458 2-s2.0-0033401226 10.1046/j.1365-2990.1999.00200. x (Pubitemid 30045419)
182. Dowling P., Shang G., Raval S., Menonna J., Cook S., Husar W., Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain. Journal of Experimental Medicine 1996 184 4 1513 1518 2-s2.0-0029960673 10.1084/jem.184.4.1513 (Pubitemid 26354706)
183. Pouly S., Becher B., Blain M., Antel J. P., Interferon- γ modulates human oligodendrocyte susceptibility to Fas-mediated apoptosis. Journal of Neuropathology and Experimental Neurology 2000 59 4 280 286 2-s2.0-0034069944 (Pubitemid 30183695)
184. Höftberger R., Aboul-Enein F., Brueck W., Lucchinetti C., Rodriguez M., Schmidbauer M., Jellinger K., Lassmann H., Expression of major histocompatibility complex class I molecules on the different cell types in multiple sclerosis lesions. Brain Pathology 2004 14 1 43 50 2-s2.0-1042299971 (Pubitemid 38200588)
185. Patel J., Balabanov R., Molecular mechanisms of oligodendrocyte injury in multiple sclerosis and experimental autoimmune encephalomyelitis. International Journal of Molecular Sciences 2012 13 10647 10659
186. Bö L., Mörk S., Kong P. A., Nyland H., Pardo C. A., Trapp B. D., Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions. Journal of Neuroimmunology 1994 51 2 135 146 2-s2.0-0028231281 10.1016/0165-5728(94)90075-2 (Pubitemid 24147480)
187. Redwine J. M., Buchmeier M. J., Evans C. F., In vivo expression of major histocompatibility complex molecules on oligodendrocytes and neurons during viral infection. American Journal of Pathology 2001 159 4 1219 1224 2-s2.0-0034790728 (Pubitemid 32947951)
188. Bergsteinsdottir K., Brennan A., Jessen K. R., Mirsky R., In the presence of dexamethasone, γ interferon induces rat oligodendrocytes to express major histocompatibility complex class II molecules. Proceedings of the National Academy of Sciences of the United States of America 1992 89 19 9054 9058 2-s2.0-0026630136 10.1073/pnas.89.19.9054
189. Zhang Q., Raoof M., Chen Y., Sumi Y., Sursal T., Junger W., Brohi K., Itagaki K., Hauser C. J., Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010 464 7285 104 107 2-s2.0-77950275298 10.1038/nature08780
190. Harada K., Hide I., Seki T., Tanaka S., Nakata Y., Sakai N., Extracellular ATP differentially modulates Toll-like receptor 4-mediated cell survival and death of microglia. Journal of Neurochemistry 2011 116 6 1138 1147 2-s2.0-79952387128 10.1111/j.1471-4159.2011.07170.x
191. Junger W. G., Immune cell regulation by autocrine purinergic signalling. Nature Reviews Immunology 2011 11 3 201 212 2-s2.0-79952192382 10.1038/nri2938
192. Bal-Price A., Moneer Z., Brown G. C., Nitric oxide induces rapid, calcium-dependent release of vesicular glutamate and ATP from cultured rat astrocytes. Glia 2002 40 3 312 323 2-s2.0-0346668359 10.1002/glia.10124 (Pubitemid 36010738)
193. Parpura V., Scemes E., Spray D. C., Mechanisms of glutamate release from astrocytes: gap junction "hemichannels" purinergic receptors and exocytotic release. Neurochemistry International 2004 45 2-3 259 264 2-s2.0-2442549046 10.1016/j.neuint.2003.12.011 (Pubitemid 38625617)
194. Schenk U., Westendorf A. M., Radaelli E., Casati A., Ferro M., Fumagalli M., Verderio C., Buer J., Scanziani E., Grassi F., Purinergic control of T cell activation by ATP released through pannexin-1 hemichannels. Science Signaling 2008 1 39 ra6 2-s2.0-55649113607 10.1126/scisignal.1160583
195. Tokunaga A., Tsukimoto M., Harada H., Moriyama Y., Kojima S., Involvement of SLC17A9-dependent vesicular exocytosis in the mechanism of ATP release during T cell activation. Journal of Biological Chemistry 2010 285 23 17406 17416 2-s2.0-77952930617 10.1074/jbc.M110.112417
196. Dahlquist R., Diamant B., Interaction of ATP and calcium on the rat mast cell: Effect on histamine release. Acta Pharmacologica et Toxicologica 1974 34 5 368 384 2-s2.0-0016198398
197. McCloskey M. A., Fan Y., Luther S., Chemotaxis of rat mast cells toward adenine nucleotides. Journal of Immunology 1999 163 2 970 977 2-s2.0-0033565879 (Pubitemid 29328109)
198. Bulanova E., Budagian V., Orinska Z., Hein M., Petersen F., Thon L., Adam D., Bulfone-Paus S., Extracellular ATP induces cytokine expression and apoptosis through P2X7 receptor in murine mast cells. Journal of Immunology 2005 174 7 3880 3890 2-s2.0-15444379876 (Pubitemid 40395960)
199. Suzuki R., Furuno T., McKay D. M., Wolvers D., Teshima R., Nakanishi M., Bienenstock J., Direct neurite-mast cell communication in vitro occurs via the neuropeptide substance P. Journal of Immunology 1999 163 5 2410 2415 2-s2.0-0033198279 (Pubitemid 29399159)
200. Hudson C. A., Christophi G. P., Gruber R. C., Wilmore J. R., Lawrence D. A., Massa P. T., Induction of IL-33 expression and activity in central nervous system glia. Journal of Leukocyte Biology 2008 84 3 631 643 2-s2.0-50849142256 10.1189/jlb.1207830
201. Zhang B., Asadi S., Weng Z., Sismanopoulos N., Theoharides T. C., Stimulated human mast cells secrete mitochondrial components that have autocrine and paracrine inflammatory actions. PLoS ONE 2012 7 10.1371/journal.pone. 0049767 e49767
202. Theoharides T. C., Spanos C., Pang X., Alferes L., Ligris K., Letourneau R., Rozniecki J. J., Webster E., Chrousos G. P., Stress-induced intracranial mast cell degranulation: A corticotropin-releasing hormone-mediated effect. Endocrinology 1995 136 12 5745 5750 2-s2.0-0028866220
203. Theoharides T. C., Singh L. K., Boucher W., Pang X., Letourneau R., Webster E., Chrousos G., Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects. Endocrinology 1998 139 403 413 10.1210/en.139.1.403 (Pubitemid 28166335)
204. Cao J., Papadopoulou N., Kempuraj D., Boucher W. S., Sugimoto K., Cetrulo C. L., Theoharides T. C., Human mast cells express corticotropin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor. Journal of Immunology 2005 174 12 7665 7675 2-s2.0-20444366589 (Pubitemid 40806271)
205. Esposito P., Chandler N., Kandere K., Basu S., Jacobson S., Connolly R., Tutor D., Theoharides T. C., Corticotropin-releasing hormone and brain mast cells regulate blood-brain-barrier permeability induced by acute stress. Journal of Pharmacology and Experimental Therapeutics 2002 303 3 1061 1066 2-s2.0-0036896468 10.1124/jpet.102.038497 (Pubitemid 35424390)
206. Alysandratos K. D., Asadi S., Angelidou A., Zhang B., Sismanopoulos N., Yang H., Critchfield A., Theoharides T. C., Neurotensin and CRH interactions augment human mast cell activation. PLoS ONE 2012 7 10.1371/journal.pone.0048934 e48934
207. Sugama S., Stress-induced microglial activation may facilitate the progression of neurodegenerative disorders. Medical Hypotheses 2009 73 6 1031 1034 2-s2.0-70449706451 10.1016/j.mehy.2009.02.047
208. Sugama S., Takenouchi T., Fujita M., Conti B., Hashimoto M., Differential microglial activation between acute stress and lipopolysaccharide treatment. Journal of Neuroimmunology 2009 207 1-2 24 31 2-s2.0-60149097714 10.1016/j.jneuroim.2008.11.007
209. Simard M., Couldwell W. T., Zhang W., Song H., Liu S., Cotrina M. L., Goldman S., Nedergaard M., Glucocorticoids-potent modulators of astrocytic calcium signaling. Glia 1999 28 1 12 (Pubitemid 29475574)
210. Mirescu C., Peters J. D., Gould E., Early life experience alters response of adult neurogenesis to stress. Nature Neuroscience 2004 7 8 841 846 2-s2.0-3343008569 10.1038/nn1290 (Pubitemid 38989507)
211. Gómez-González B., Escobar A., Prenatal stress alters microglial development and distribution in postnatal rat brain. Acta Neuropathologica 2010 119 3 303 315 2-s2.0-77953012930 10.1007/s00401-009-0590-4
212. Helmut K., Hanisch U.-K., Noda M., Verkhratsky A., Physiology of microglia. Physiological Reviews 2011 91 2 461 553 2-s2.0-79955605102 10.1152/physrev.00011.2010
213. Juckel G., Manitz M. P., Brüne M., Friebe A., Heneka M. T., Wolf R. J., Microglial activation in a neuroinflammational animal model of schizophrenia-a pilot study. Schizophrenia Research 2011 131 1-3 96 100 2-s2.0-80051789320 10.1016/j.schres.2011.06.018
214. Belliveau D. J., Bani-Yaghoub M., McGirr B., Naus C. C. G., Rushlow W. J., Enhanced neurite outgrowth in PC12 cells mediated by connexin hemichannels and ATP. Journal of Biological Chemistry 2006 281 30 20920 20931 2-s2.0-33746358536 10.1074/jbc.M600026200 (Pubitemid 44115433)
215. Joseph D. J., Williams D. J., MacDermott A. B., Modulation of neurite outgrowth by activation of calcium-permeable kainate receptors expressed by rat nociceptive-like dorsal root ganglion neurons. Developmental Neurobiology 2011 71 10 818 835 2-s2.0-80052639130 10.1002/dneu.20906
216. Frank M. G., Watkins L. R., Maier S. F., Stress- and glucocorticoid- induced priming of neuroinflammatory responses: Potential mechanisms of stress-induced vulnerability to drugs of abuse. Brain, Behavior, and Immunity 2011 25 1 S21 S28 2-s2.0-79955720084 10.1016/j.bbi.2011.01.005
217. Goujon E., Parnet P., Laye S., Combe C., Kelley K. W., Dantzer R., Stress downregulates lipopolysaccharide-induced expression of proinflammatory cytokines in the spleen, pituitary, and brain of mice. Brain, Behavior, and Immunity 1995 9 4 292 303 2-s2.0-0029610919 10.1006/brbi.1995.1028 (Pubitemid 26039769)
218. Anisman H., Cascading effects of stressors and inflammatory immune system activation: Implications for major depressive disorder. Journal of Psychiatry and Neuroscience 2009 34 1 4 20 2-s2.0-60849106515
219. Pace T. W. W., Miller A. H., Cytokines and glucocorticoid receptor signaling: Relevance to major depression. Annals of the New York Academy of Sciences 2009 1179 86 105 2-s2.0-70449376943 10.1111/j.1749-6632.2009.04984.x
220. Gouin J.-P., Hantsoo L., Kiecolt-Glaser J. K., Immune dysregulation and chronic stress among older adults: A review. NeuroImmunoModulation 2008 15 4-6 251 259 2-s2.0-57149104111 10.1159/000156468
221. Nakata A., Psychosocial job stress and immunity: A systematic review. Methods in Molecular Biology 2012 934 39 75
222. Angelidou A., Asadi S., Alysandratos K. D., Karagkouni A., Kourembanas S., Theoharides T. C., Perinatal stress, brain inflammation and risk of autism-review and proposal. BMC Pediatrics 2012 12 89
223. Garate I., Garcia-Bueno B., Madrigal J. L., Caso J. R., Alou L., Gomez-Lus M. L., Mico J. A., Leza J. C., Stress-induced neuroinflammation: Role of the Toll-like receptor-4 pathway. Biological Psychiatry 2013 73 32 43
224. Frischer J. M., Bramow S., Dal-Bianco A., Lucchinetti C. F., Rauschka H., Schmidbauer M., Laursen H., Sorensen P. S., Lassmann H., The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 2009 132 5 1175 1189 2-s2.0-66549130329 10.1093/brain/awp070
225. Theoharides T. C., Zhang B., Conti P., Decreased mitochondrial function and increased brain inflammation in bipolar disorder and other neuropsychiatric diseases. Journal of Clinical Psychopharmacology 2011 31 6 685 687 2-s2.0-80755163162 10.1097/JCP.0b013e318239c190
226. Hagberg H., Gressens P., Mallard C., Inflammation during fetal and neonatal life: Implications for neurologic and neuropsychiatric disease in children and adults. Annals of Neurology 2012 71 4 444 457 2-s2.0-84860222551 10.1002/ana.22620
227. Vasiadi M., Therianou A., Sideri K., Smyrnioti M., Sismanopoulos N., Delivanis D. A., Asadi S., Katsarou-Katsari A., Petrakopoulou T., Theoharides A., Antoniou C., Papadavid E., Stavrianeas N., Kalogeromitros D., Theoharides T. C., Increased serum CRH levels with decreased skin CRHR-1 gene expression in psoriasis and atopic dermatitis. Journal of Allergy and Clinical Immunology 2012 129 5 1410 1413 2-s2.0-84860463864 10.1016/j.jaci.2012.01.041
228. Sanders P., De Keyser J., Janus faces of microglia in multiple sclerosis. Brain Research Reviews 2007 54 2 274 285 2-s2.0-34250028381 10.1016/j.brainresrev.2007.03.001 (Pubitemid 46891077)
229. de Vries H. E., Kuiper J., De Boer A. G., Van Berkel T. J. C., Breimer D. D., The blood-brain barrier in neuroinflammatory diseases. Pharmacological Reviews 1997 49 2 143 155 2-s2.0-0030791228 (Pubitemid 27291032)
230. Tuomisto L., Kilpeläinen H., Riekkinen P., Histamine and histamine-N-methyltransferase in the CSF of patients with multiple sclerosis. Agents and Actions 1983 13 2-3 255 257 2-s2.0-0020744731 10.1007/BF01967346
231. Kinney D. K., Munir K. M., Crowley D. J., Miller A. M., Prenatal stress and risk for autism. Neuroscience and Biobehavioral Reviews 2008 32 8 1519 1532 2-s2.0-52049113008 10.1016/j.neubiorev.2008.06.004
232. Chrousos G. P., Epstein F., Flier J., Reichlin S., Pavlou S., The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. The New England Journal of Medicine 1995 332 20 1351 1362 2-s2.0-0029037126 10.1056/NEJM199505183322008
233. Theoharides T. C., Donelan J. M., Papadopoulou N., Cao J., Kempuraj D., Conti P., Mast cells as targets of corticotropin-releasing factor and related peptides. Trends in Pharmacological Sciences 2004 25 11 563 568 2-s2.0-5644257402 10.1016/j.tips.2004.09.007 (Pubitemid 39371146)
234. Theoharides T. C., Konstantinidou A. D., Corticotropin-releaslng hormone and the blood-brain-barrier. Frontiers in Bioscience 2007 12 5 1615 1628 2-s2.0-34248150697 10.2741/2174 (Pubitemid 46846794)
235. Abbott N. J., Inflammatory mediators and modulation of blood-brain barrier permeability. Cellular and Molecular Neurobiology 2000 20 2 131 147 2-s2.0-0033962411 10.1023/A:1007074420772 (Pubitemid 30091452)
236. Giulivi C., Zhang Y.-F., Omanska-Klusek A., Ross-Inta C., Wong S., Hertz-Picciotto I., Tassone F., Pessah I. N., Mitochondrial dysfunction in autism. Journal of the American Medical Association 2010 304 21 2389 2396 2-s2.0-78649758904 10.1001/jama.2010.1706
237. Palmieri L., Persico A. M., Mitochondrial dysfunction in autism spectrum disorders: Cause or effect? Biochimica et Biophysica Acta 2010 1797 6-7 1130 1137 2-s2.0-77953809304 10.1016/j.bbabio.2010.04.018
238. Frye R. E., Rossignol D. A., Mitochondrial dysfunction can connect the diverse medical symptoms associated with autism spectrum disorders. Pediatric Research 2011 69 5 2-s2.0-79954614882 10.1203/PDR.0b013e318212f16b
239. Enstrom A. M., Van De W. A. J., Ashwood P., Autoimmunity in autism. Current Opinion in Investigational Drugs 2009 10 5 463 473 2-s2.0-67649414374
240. Theoharides T. C., Kempuraj D., Redwood L., Autism: An emerging "neuroimmune disorder" in search of therapy. Expert Opinion on Pharmacotherapy 2009 10 13 2127 2143 2-s2.0-68949159751 10.1517/ 14656560903107789
241. Goines P., Van De Water J., The immune system's role in the biology of autism. Current Opinion in Neurology 2010 23 2 111 117 2-s2.0-77949343048 10.1097/WCO.0b013e3283373514
242. Wills S., Cabanlit M., Bennett J., Ashwood P., Amaral D. G., Van de Water J., Detection of autoantibodies to neural cells of the cerebellum in the plasma of subjects with autism spectrum disorders. Brain, Behavior, and Immunity 2009 23 1 64 74 2-s2.0-56949085021 10.1016/j.bbi.2008.07.007
243. Zhang B., Angelidou A., Alysandratos K.-D., Vasiadi M., Francis K., Asadi S., Theoharides A., Sideri K., Lykouras L., Kalogeromitros D., Theoharides T. C., Mitochondrial DNA and anti-mitochondrial antibodies in serum of autistic children. Journal of Neuroinflammation 2010 7, article 80 2-s2.0-78349286789 10.1186/1742-2094-7-80
244. Angelidou A., Francis K., Vasiadi M., Alysandratos K.-D., Zhang B., Theoharides A., Lykouras L., Sideri K., Kalogeromitros D., Theoharides T. C., Neurotensin is increased in serum of young children with autistic disorder. Journal of Neuroinflammation 2010 7, article 48 2-s2.0-77955834453 10.1186/1742-2094-7-48
245. Zhang B., Alysandratos K.-D., Angelidou A., Asadi S., Sismanopoulos N., Delivanis D.-A., Weng Z., Miniati A., Vasiadi M., Katsarou-Katsari A., Miao B., Leeman S. E., Kalogeromitros D., Theoharides T. C., Human mast cell degranulation and preformed TNF secretion require mitochondrial translocation to exocytosis sites: Relevance to atopic dermatitis. Journal of Allergy and Clinical Immunology 2011 127 6 1522 e8 2-s2.0-79957839365 10.1016/j.jaci.2011. 02.005
246. von zur Muhlen F., Eckstein F., Penner R., Guanosine 5′ -[ β -thio]triphosphate selectively activates calcium signaling in mast cells. Proceedings of the National Academy of Sciences of the United States of America 1991 88 3 926 930 2-s2.0-0025974263 10.1073/pnas.88.3.926 (Pubitemid 21916137)
247. Gibb J., Hayley S., Gandhi R., Poulter M. O., Anisman H., Synergistic and additive actions of a psychosocial stressor and endotoxin challenge: Circulating and brain cytokines, plasma corticosterone and behavioral changes in mice. Brain, Behavior, and Immunity 2008 22 4 573 589 2-s2.0-41349110178 10.1016/j.bbi.2007.12.001
248. Shi L., Smith S. E. P., Malkova N., Tse D., Su Y., Patterson P. H., Activation of the maternal immune system alters cerebellar development in the offspring. Brain, Behavior, and Immunity 2009 23 1 116 123 2-s2.0-56949092229 10.1016/j.bbi.2008.07.012
249. Hinkerohe D., Wolfkühler D., Haghikia A., Meier C., Faustmann P. M., Schlegel U., Dexamethasone differentially regulates functional membrane properties in glioma cell lines and primary astrocytes in vitro. Journal of Neuro-Oncology 2011 103 3 479 489 2-s2.0-79959807596 10.1007/s11060-010-0456-6
250. Gibb J., Hayley S., Poulter M. O., Anisman H., Effects of stressors and immune activating agents on peripheral and central cytokines in mouse strains that differ in stressor responsivity. Brain, Behavior, and Immunity 2011 25 3 468 482 2-s2.0-79551684081 10.1016/j.bbi.2010.11.008
251. Hayley S., Mangano E., Strickland M., Anisman H., Lipopolysaccharide and a social stressor influence behaviour, corticosterone and cytokine levels: Divergent actions in cyclooxygenase-2 deficient mice and wild type controls. Journal of Neuroimmunology 2008 197 1 29 36 2-s2.0-44649187454 10.1016/j.jneuroim.2008.03.015
252. Bilbo S. D., Schwarz J. M., Early-life programming of later-life brain and behavior: A critical role for the immune system. Frontiers in Behavioral Neuroscience 2009 3 14 10.3389/neuro.08.014.2009
253. Kato T. A., Kanba S., Are microglia minding us? Digging up the unconscious mind-brain relationship from a neuropsychoanalytic approach. Frontiers in Human Neuroscience 2013 7 13 10.3389/fnhum.2013.00013